United States Retail Clinics Market Trends

Point of care diagnostics holds the largest shares in the market, owing to presence of better healthcare infrastructure, increasing cases of infectious diseases, a growing geriatric population base, and high-quality diagnostic tests that are widely available. According to the estimates of the American Cancer Society, in 2021, an estimated 1,898,160 new cases of cancer may be diagnosed in the United States, and 608,570 people may die from the disease. In the future, this number may increase insignificantly over the year, which is expected to drive the growth in the studied market in the country. According to the Centers for Disease Control and Prevention report of 2019 on infectious diseases, there were 9,025 new cases of tuberculosis, 60,999 new cases of salmonella, 33,666 new cases of Lyme disease, and 327 new cases of meningococcal disease in 2018. For the primary diagnosis of infectious and parasitic diseases, the number of visits to the physician's office was 15.5 million. The rising prevalence of chronic diseases may significantly drive the studied market in the United States. Additionally, chronic diseases such as heart disease are a leading cause of death that creates an enormous burden on people, communities, healthcare providers, and systems. According to the American Heart Association Research Report 2021, between 2015 and 2018, around 126.9 million American adults had some form of cardiovascular disease (CVD); this indicates the increased use of therapeutics for cardiology-related issues may boost the market over the studied period.

Therefore, access to sensitive and rapid infectious disease diagnostic assays is essential for accurate diagnosis, effective treatment, and timely infection control, making point-of-care tests vital to reducing turnaround time and promoting the growth of retail clinics in the market.